Development of artificial intelligence (AI) tools to understand and duplicate experts radiation therapy planning for prostate cancer
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91019C00044
- Awardee
-
Oncospace Inc. UEI HSG5CY5VWW33
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $299,433
Award facts
- Opportunity
-
- PHS2019 Solicitation number
- Contract value 84% obligated
-
- $299,433.00 Current, with exercised options
- $354,415.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21205, USA
- Research
- SBIR Program Phase I Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Original award | $299,433 |
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $354,415.00 Firm Fixed Price contract to Oncospace Inc., a Baltimore-based small business, to develop artificial intelligence (AI) tools to understand and duplicate expert radiation therapy planning for prostate cancer. This contract is part of the Small Business Innovation Research (SBIR) program and builds upon prior SBIR and National Science Foundation awards to Oncospace Inc. totaling over $3.4 million for developing AI and data analytics solutions to optimize radiation therapy outcomes, including treatment planning standardization and quality assurance. The contract is focused on creating AI models to automate and standardize radiation therapy planning for prostate cancer.
Quick answers
Who was awarded contract 75N91019C00044?
75N91019C00044 was awarded to Oncospace Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2019.
How much is contract 75N91019C00044 worth?
The government has obligated $299,433 on 75N91019C00044. Its potential value, with all options, is $354,415.
Was contract 75N91019C00044 competed?
The extent of competition for 75N91019C00044 was full and open competition after exclusion of sources. The government received 7 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award